Who We Are
|
Our Mission The fight against infections is not bound by the walls of hospitals. Anyone who works with groups of people is at risk; while many understand this, unfortunately their defense has been limited to the same outdated technology for decades — alcohol-based hand sanitizers. Advanced Biomedical’s mission is to put the power back into the hands of people worldwide with its proprietary time release formulation that enables its hand sanitizing lotion, DuraShield®, to be effective for hours against a wider range of pathogens.  Our BackgroundThe technology for our formulation was originally developed for use in wound care centers for the treatment of open wounds on seriously ill patients often suffering from extremely suppressed immune systems or new skin grafts. Well over one hundred tests were conducted to ensure an effective, long-lasting barrier against pathogens and satisfy the peer review boards and hospital administrators. The product passed all tests and met all requirements of the hospitals, and was thus introduced into the wound care centers. The next step was to develop a hand sanitizing lotion, DuraShield®, which would possess those proven attributes but with additional development, with an emphasis on safety. Further testing confirmed there was no toxicity or detrimental effects to eyes associated with the product. There is also no risk of flammability, unlike alcohol-based hand sanitizers. Thus, DuraShield® improves the health and safety of its users, while eliminating the undesirable side effects and limitations that have become the standard for years with alcohol-based hand sanitizers. DuraShield®, the result of decades worth of research and development, is the remarkably applicable hand sanitizer needed in this time of spreading pandemics. Further tests are being conducted to ensure the product remains effective against emerging pathogens and suits our clients' specific needs. |
|
Our Mission The fight against infections is not bound by the walls of hospitals. Anyone who works with groups of people is at risk; while many understand this, unfortunately their defense has been limited to the same outdated technology for decades — alcohol-based hand sanitizers. Advanced Biomedical’s mission is to put the power back into the hands of people worldwide with its proprietary time release formulation that enables its hand sanitizing lotion, DuraShield®, to be effective for hours against a wider range of pathogens. Our BackgroundThe technology for our formulation was originally developed for use in wound care centers for the treatment of open wounds on seriously ill patients often suffering from extremely suppressed immune systems or new skin grafts. Well over one hundred tests were conducted to ensure an effective, long-lasting barrier against pathogens and satisfy the peer review boards and hospital administrators. The product passed all tests and met all requirements of the hospitals, and was thus introduced into the wound care centers. The next step was to develop a hand sanitizing lotion, DuraShield®, which would possess those proven attributes but with additional development, with an emphasis on safety. Further testing confirmed there was no toxicity or detrimental effects to eyes associated with the product. There is also no risk of flammability, unlike alcohol-based hand sanitizers. Thus, DuraShield® improves the health and safety of its users, while eliminating the undesirable side effects and limitations that have become the standard for years with alcohol-based hand sanitizers. DuraShield®, the result of decades worth of research and development, is the remarkably applicable hand sanitizer needed in this time of spreading pandemics. Further tests are being conducted to ensure the product remains effective against emerging pathogens and suits our clients' specific needs. |
